ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
COZMOS: Phase I/Ib trial of combined 5’azacitidine and carboplatin for recurrent/refractory pediatric brain and solid tumours
Protocol ID
OZM-077 (COZMOS)
Condition/s
Ependymoma
Diagnosis Stage
Relapse/ refractory
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
The Hospital for Sick Children
Links
External Registry ≫
Trial Status
Closed to Recruitment
Study Type
Treatment
Phase
Phase 1
Age Eligibility
1 year to 18 years
International registry ID's
NCT03206021
Back to Registry
Study Title COZMOS: Phase I/Ib trial of combined 5’azacitidine and carboplatin for recurrent/refractory pediatric brain and solid tumours
Protocol ID OZM-077 (COZMOS)
Disease (Sub Disease) Ependymoma
Diagnosis Stage Relapse/ refractory
Sponsor Australian and New Zealand Children's Haematology Oncology Group/ The Hospital for Sick Children
Links https://clinicaltrials.gov/ct2/show/NCT03206021
Trial Status Closed to Recruitment
Trial Open Date 01/09/2019
Study Type Treatment
Phase Phase 1
Age Eligibility 1 year to 18 years
International registry ID's NCT03206021

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168

ANZCHOG acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures, and to Elders both past and present. We acknowledge Māori as tangata whenua of Aotearoa New Zealand and as Treaty partners with the Crown as agreed in Te Tiriti o Waitangi. 

We are committed to creating a safe and welcoming environment that embraces all backgrounds, cultures, sexualities, genders and abilities.